Skip to main content
MAYNE PHARMA GROUP LIMITED logo

MAYNE PHARMA GROUP LIMITED — Investor Relations & Filings

Ticker · MYX ISIN · AU000000MYX0 LEI · 549300VIRDEN0N4MJG59 ASX Manufacturing
Open in API
Filings indexed 1,118 across all filing types
Latest filing 2023-03-29 Transaction in Own Shar…
Country AU Australia
Listing ASX MYX

About MAYNE PHARMA GROUP LIMITED

https://www.maynepharma.com

Mayne Pharma Group Limited is a specialty pharmaceutical company focused on the development and commercialization of branded and generic medicines. The company operates through specialized segments including Women's Health and Dermatology. Its Women's Health portfolio features innovative contraceptive solutions, while the Dermatology division provides a broad range of treatments for various skin conditions. Beyond its product portfolio, the company provides contract development and manufacturing services (CDMO), leveraging proprietary drug delivery technologies to produce complex oral and topical dosage forms. The organization focuses on high-growth specialty markets, aiming to deliver differentiated therapeutic options and improve patient outcomes through technical excellence and strategic commercialization.

Recent filings

Filing Released Lang Actions
Notification of buy-back - MYX 5 pages 24.9KB
Transaction in Own Shares Classification · 100% confidence The document is titled 'Notification of buy-back' and details a buy-back of shares by Mayne Pharma Group Limited. It specifies the type of buy-back as an 'Employee share scheme buy-back', provides details on the number of securities involved, the consideration (extinguishment of employee share loans), and key dates. There is no indication of financial statements or comprehensive financial analysis, but rather a specific announcement about the company's repurchase of its own shares. This fits the definition of 'Transaction in Own Shares' (POS), which covers reports of the company buying back or selling its own shares.
2023-03-29 English
Change of Director's Interest Notice 2 pages 244.5KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details the change in securities holdings of a director, including dates, number of shares acquired, and value. The content is focused on reporting personal share transactions by a company director. The document length is 3229 characters, which is consistent with a detailed notice of director dealings rather than a brief announcement or a full report. Therefore, this document fits the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades).
2023-03-26 English
Update on convertible note arrangements with Rubric Capital 2 pages 147.9KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement providing an update on convertible note arrangements with Rubric Capital Management LP. It details the terms of the convertible notes issued, adjustments following a special dividend and share consolidation, and related governance provisions such as the appointment of a Board Observer and standstill provisions. The content focuses on financing activities and capital structure changes rather than financial results or regulatory certifications. The document length is 3600 characters, which is relatively short and typical for an announcement rather than a full report. There is no indication that this is a full financial report, audit, or earnings release. Therefore, the document best fits the category of Capital/Financing Update (CAP).
2023-03-22 English
Change in substantial holding 7 pages 665.0KB
Major Shareholding Notification Classification · 100% confidence The document is titled 'Form 604' and is a 'Notice of change of interests of substantial holder' under the Corporations Act 2001. It details changes in voting power and relevant interests of a substantial shareholder, Lazard Asset Management Pacific Co, including annexures listing associates and specific share transactions. This type of filing is a notification of changes in significant share ownership levels, which matches the definition of 'Major Shareholding Notification'. The document is not an annual report, earnings release, or any other financial report but a regulatory notice about shareholding changes.
2023-03-15 English
Becoming a substantial holder 7 pages 606.2KB
Major Shareholding Notification Classification · 100% confidence The document is titled 'Form 603' and references the Corporations Act 2001, Section 671B, which pertains to notices of initial substantial holders. It details the substantial shareholding of Lazard Asset Management Pacific Co in Mayne Pharma Group Limited, including voting power, relevant interests, registered holders, consideration paid, and associates. The document is a formal regulatory notice about a change in significant share ownership, not a financial report or earnings release. It fits the definition of a Major Shareholding Notification, which reports changes in significant share ownership levels crossing thresholds.
2023-03-02 English
Half Yearly Report and Accounts 44 pages 1.2MB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Mayne Pharma Group Limited Interim Results' and includes an Appendix 4D Half Year Report, Directors’ Report, Financial Report, and Auditor’s Independent Review Report for the half-year ended 31 December 2022. It contains detailed financial statements, directors' commentary, segment analysis, and auditor's review, all typical components of an interim or quarterly financial report. The document length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement or certification. The presence of half-year financial data and analysis confirms it is an Interim / Quarterly Report (IR). H1 2023
2023-02-27 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.